• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Model Number 9-PDA-009
Device Problems Migration or Expulsion of Device (1395); Improper or Incorrect Procedure or Method (2017); Malposition of Device (2616); Connection Problem (2900)
Patient Problem Embolism (1829)
Event Date 03/05/2020
Event Type  malfunction  
Manufacturer Narrative
An event of a device premature release with subsequent embolization when attempting to retract the device after it failed to fully occlude the defect was reported.The results of the investigation are inconclusive since the device remains implanted and was not accessible for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Please note, per the instructions for use artmt100092302 rev.A, "the amplatzer¿ duct occluder is a percutaneous, transcatheter occlusion device intended for the nonsurgical closure of a patent ductus arteriosus (pda)," and is not indicated for closure of a ruptured sinus of valsalva aneurysm.This may have contributed to the reported residual shunt.The cause of the device release and subsequent embolization could not be conclusively determined.
 
Event Description
Reference manufacturing report number: 2135147-2020-00140.On (b)(6) 2020, a 16-14 amplatzer duct occluder was selected for implant for a sinus valsalva aneurysm with an 8f/45 torqvue delivery system.After deploying the device and prior to release, the physician was not satisfied with the positioning of the device.The physician attempted to retract the device, but it prematurely released from the delivery system and embolized to the pulmonary artery.A 10f/45 torqvue delivery system was used to retrieve the device without success.The patient was stable when referred to surgery to retrieve the device and close the defect.There were no patient consequences.No additional information.
 
Manufacturer Narrative
Correction information for d2 additional information for g4, g7, h2, h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER DUCT OCCLUDER
Type of Device
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key9900927
MDR Text Key186212528
Report Number2135147-2020-00139
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 12/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/30/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2022
Device Model Number9-PDA-009
Device Lot Number5993660
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AMPLATZER TORQVUE DELIVERY SYSTEM.
Patient Outcome(s) Required Intervention;
-
-